Melanoma thickness trends in the United States, 1988-2006

Journal of Investigative Dermatology

Volumn 130, Issue 3, 2010, Pages 793-797

  Criscione, Vincent D ^a,b   Weinstock, Martin A ^a,b  

^a BROWN UNIVERSITY   (United States)

^b PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SCREENING; CANCER SIZE; DEMOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME; UNITED STATES;

CARCINOMA IN SITU; HUMANS; MELANOMA; PROGNOSIS; REGISTRIES; SEER PROGRAM; SKIN NEOPLASMS; SURVIVAL ANALYSIS; UNITED STATES;

EID: 76649102084     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2009.328     Document Type: Article

References (30)

1. Aitken J, Janda M, Elwood M, Youl P, Ring I, Lowe J (2006a) Clinical outcomes from skin screening clinics within a community-based melanoma screening program. J Am Acad Dermatol 54:105-114 (Pubitemid 41832466)
2. Aitken J, Youl PMJ, Lowe J, Ring I, Elwood M (2006b) Increase in skin cancer screening during a community-based randomized intervention trial. Int J Cancer 118:1010-1016 (Pubitemid 43157679)
3. Burton R, Armstrong B (1998) Non-metastasizing melanoma? J Surg Oncol 67:73-76
4. Charles C, Yee V, Dusza S, Marghoob A, Oliveria S, Kopf A et al. (2005) Variation in the diagnosis, treatment, and management of melanoma in situ: a survey of US dermatologists. Arch Dermatol 141:723-729
5. Clegg L, Feuer E, Midthune D, Fay M, Hankey B (2002) Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst 94:1537-1545
6. Cockburn M, Swetter SM, Peng D, Keegan T, Deapen D, Clarke CA (2008) Melanoma underreporting: why does it happen, how big is the problem. J Am Acad Dermatol 59:1081-1085
7. Coory M, Baade P, Aitken J, Smithers M, Roderick G, Mcleod C et al. (2006) Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002. Cancer Causes Control 17:21-27
8. Demierre MF, Chung C, Miller D, Geller A (2005) Early detection of thick melanomas in the United States: beware of the nodular subtype. Arch Dermatol 141:745-750
9. Dennis LK (1999) Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 surveillance, epidemiology, and end results program registry. Arch Dermatol 135:275-280
10. Eide M, Weinstock M, Clark M (2009) Demographic and socioeconomic predictors of melanoma prognosis in the United States. J Health Care Poor Underserved 20:227-245
11. Garbe C, McLeod G, Buettner P (2000) Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer 89:1269-1278
12. Geller A (2009) Educational and screening campaigns to reduce deaths from melanoma. Hematol Oncol Clin North Am 23:515-527
13. Geller A, Miller D, Swetter SM, Demierre MF, Gilchrest B (2006) A call for the development and implementation of a targeted national melanoma screening program. Arch Dermatol 142:504-507
14. Geller A, Zhang Z, Sober AJ, Halpern A, Weinstock M, Daniels S et al. (2003) The first 15 years of the American Academy of Dermatology skin cancer screening programs: 1985-1999. J Am Acad Dermatol 48:34-41
15. Geller J, Swetter SM, Leyson J, Miller D, Brooks K, Geller A (2007) Screening, early detection, and trends for melanoma: current status (2000-2006) and future directions. J Am Acad Dermatol 57:555-572
16. Heymann WR (2007) Screening for melanoma. J Am Acad Dermatol 56:144-145
17. Koh H (2007) Melanoma screening: focusing the public health journey. Arch Dermatol 143:101-103
18. Lee K, Weinstock M (2009) Melanoma is up: are we up to this challenge? J Invest Dermatol 129:1604-1606
19. Linos E, Swetter SM, Cockburn MG, Colditz MG, Clarke CA (2009) Increasing burden of melanoma in the United States. J Invest Dermatol 129:1666-1674
20. Lipsker D, Engel F, Cribier B, Velten M, Hedelin G (2007) Trends in melanoma epidemiology suggest three different types of melanoma. Br J Dermatol 157:338-343
21. Mackie R, Bray C, Hole D, Morris A, Nicolson M, Evans A et al. (2002) Incidence of and survival from malignant melanoma in Scotland: an epidemiologic study. Lancet 360:587-591
22. Merlino L, Sullivan K, Whitaker D, Lynch C (1997) The independent pathology laboratory as a reporting source for cutaneous melanoma incidence in Iowa, 1977-1994. J Am Acad Dermatol 37:578-585
23. Moore M, Geller A, Zhang Z, Hayes B, Bergstrom K, Graves J et al. (2006) Skin cancer examination teaching in US medical education. Arch Dermatol 142:439-444
24. Murray CS, Stockton DL, Doherty VR (2005) Thick melanoma: the challenge persists. Br J Dermatol 152:104-109
25. Santmyire B, Feldman S, Fleischer A (2001) Lifestyle high-risk behaviors and demographics may predict the level of participation in sun-protection behaviors and skin cancer primary prevention in the United States: results of the 1998 National Health Interview Survey. Cancer 92:1315-1324
26. Schneider J, Moore D, Mendelsohn M (2008) Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996. J Am Acad Dermatol 58:741-749
27. SEER (2008) Surveillance, Epidemiology, and End Results Program. Available at www.seer.cancer.gov. Limited-use data (1973-2006), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2009, based on the November 2008 submission.
28. Tejera-Vaquerizo A, Mendiola-Fernandez M, Fernandez-Orland A, Herrera-Ceballos E (2008) Thick melanoma: the problem continues. J Eur Acad Dermatol Venereol 22:575-579
29. Weinstock M, Martin R, Risica P, Bwerwick M, Lasater T, Rakowski W et al. (1999) Thorough skin examination for the early detection of melanoma. Am J Prev Med 17:169-175
30. Weinstock M, Risica P, Martin R, Rakowski W, Smith K, Berwick M et al. (2004) Reliability of assessment and circumstances of performance of thorough skin self-examination for the early detection of melanoma in the Check-It-Out Project. Prev Med 38:761-765